Terheyden P - Search Results

1

Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma.

Spassova I, Ugurel S, Terheyden P, Sucker A, Hassel JC, Ritter C, Kubat L, Habermann D, Farahpour F, Saeedghalati M, Peiffer L, Kumar R, Schrama D, Hoffmann D, Schadendorf D, Becker JC. Spassova I, et al. Among authors: terheyden p. Clin Cancer Res. 2020 May 1;26(9):2257-2267. doi: 10.1158/1078-0432.CCR-19-2244. Epub 2020 Jan 13. Clin Cancer Res. 2020. PMID: 31932494

2

Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series.

Terheyden P, Sunderkötter C, Söhngen FD, Golle L, Schimo S, Baron R, Maihöfner C, Binder A, Pönisch W. Terheyden P, et al. Dermatol Ther (Heidelb). 2023 Oct;13(10):2461-2471. doi: 10.1007/s13555-023-01019-6. Epub 2023 Sep 13. Dermatol Ther (Heidelb). 2023. PMID: 37704912 Free PMC article.

3

Molecular basis of T-cell dysfunction in melanoma.

Becker JC, Terheyden P, Bröcker EB. Becker JC, et al. Among authors: terheyden p. Melanoma Res. 1997 Aug;7 Suppl 2:S51-7. Melanoma Res. 1997. PMID: 9578417 Review.

4

Lichen planus associated with Becker's nevus.

Terheyden P, Hornschuh B, Karl S, Becker JC, Bröcker EB. Terheyden P, et al. J Am Acad Dermatol. 1998 May;38(5 Pt 1):770-2. doi: 10.1016/s0190-9622(98)70211-7. J Am Acad Dermatol. 1998. PMID: 9591828 No abstract available.

5

[Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature].

Terheyden P, Kämpgen E, Rünger TM, Bröcker EB, Becker JC. Terheyden P, et al. Hautarzt. 1998 Oct;49(10):770-3. doi: 10.1007/s001050050823. Hautarzt. 1998. PMID: 9857252 Review. German.

6

Predominant expression of Fas (CD95) ligand in metastatic melanoma revealed by longitudinal analysis.

Terheyden P, Siedel C, Merkel A, Kämpgen E, Bröcker EB, Becker JC. Terheyden P, et al. J Invest Dermatol. 1999 Jun;112(6):899-902. doi: 10.1046/j.1523-1747.1999.00607.x. J Invest Dermatol. 1999. PMID: 10383736 Free article.

7

Function and dysfunction of CD4(+) T cells in the immune response to melanoma.

Fischer WH, thor Straten P, Terheyden P, Becker JC. Fischer WH, et al. Among authors: terheyden p. Cancer Immunol Immunother. 1999 Oct;48(7):363-70. doi: 10.1007/s002620050587. Cancer Immunol Immunother. 1999. PMID: 10501848 Free PMC article. Review.

8

Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma.

Vetter CS, Straten PT, Terheyden P, Zeuthen J, Bröcker EB, Becker JC. Vetter CS, et al. Among authors: terheyden p. J Invest Dermatol. 2000 May;114(5):941-7. doi: 10.1046/j.1523-1747.2000.00958.x. J Invest Dermatol. 2000. PMID: 10771475 Free article.

9

CD40-ligated dendritic cells effectively expand melanoma-specific CD8+ CTLs and CD4+ IFN-gamma-producing T cells from tumor-infiltrating lymphocytes.

Terheyden P, Straten P, Bröcker EB, Kämpgen E, Becker JC. Terheyden P, et al. J Immunol. 2000 Jun 15;164(12):6633-9. doi: 10.4049/jimmunol.164.12.6633. J Immunol. 2000. PMID: 10843723

10

Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma.

Terheyden P, Becker JC, Kämpgen E, Bröcker EB. Terheyden P, et al. Melanoma Res. 2000 Oct;10(5):475-82. doi: 10.1097/00008390-200010000-00010. Melanoma Res. 2000. PMID: 11095409 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters